These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29554)

  • 1. Ocular hypotensive efficacy of topical epinephrine in normotensive and hypertensive rabbits: continuous drug delivery vs eyedrops.
    Birss SA; Longwell A; Heckbert S; Keller N
    Ann Ophthalmol; 1978 Aug; 10(8):1045-54. PubMed ID: 29554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH dependency of effect of topically applied dipivefrine hydrochloride on intraocular pressure and pupil size in rabbits: comparative studies with epinephrine.
    Yamauchi H; Sasano M; Iso T
    Jpn J Ophthalmol; 1988; 32(2):187-95. PubMed ID: 3184552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
    Crosson CE; Petrovich M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ocular hypotensive response to epinephrine in rabbits with prior dexamethasone treatment.
    Rom ME; Schwartz B; Ungricht AL; Lee W
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):313-20. PubMed ID: 9261767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits.
    Stein PJ; Clack JW
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2765-8. PubMed ID: 8188470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization to topical epinephrine in the rabbit eye: attenuation by dexamethasone.
    Harris MA; Schwartz B
    Invest Ophthalmol Vis Sci; 1986 Dec; 27(12):1737-40. PubMed ID: 3793403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biphasic intraocular pressure response of rabbits to epinephrine.
    Langham ME; Krieglstein GK
    Invest Ophthalmol; 1976 Feb; 15(2):119-27. PubMed ID: 1245385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery systems for topical ophthalmic medication.
    Halberg GP; Kelly SE; Morrone M
    Ann Ophthalmol; 1975 Sep; 7(9):1199-1204, 1207-9. PubMed ID: 1163927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of topically applied pilocarpine on tear film pH.
    Longwell A; Birss S; Keller N; Moore D
    J Pharm Sci; 1976 Nov; 65(11):1654-7. PubMed ID: 11334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
    Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
    Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M; Pierce WM; Chen D; Zimmerman TJ
    Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
    Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG
    Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between hydrocortisone acetate distribution and efficacy in inflamed eyes: continuous vs intermittent delivery.
    Longwell AM; Birss SA; Keller N
    Ann Ophthalmol; 1976 May; 8(5):600-8. PubMed ID: 937943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
    Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
    Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response of dexamethasone for the enhanced ocular hypotensive response to epinephrine in rabbits with prior dexamethasone treatment.
    Schwartz B; Rom ME; Bealka N; Qi Y
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):133-9. PubMed ID: 12002667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of pilocarpine hydrochloride and epinephrine bitartrate.
    Brounley DW
    Ann Ophthalmol; 1971 Sep; 3(9):970-3 passim. PubMed ID: 5163788
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit.
    Maeda I; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E; Oguchi K; Yasuhara H
    Jpn J Ophthalmol; 1988; 32(2):211-8. PubMed ID: 3184554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits.
    Sugrue MF; O'Neill-Davis L
    J Ocul Pharmacol; 1991; 7(3):201-11. PubMed ID: 1783853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle.
    Gwin RM; Gelatt KN; Gum GG; Peiffer RL
    Am J Vet Res; 1978 Jan; 39(1):83-6. PubMed ID: 629453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.